Affiliation:
1. Kodama Animal Hospital
Publisher
Japan Veterinary Cancer Society
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference32 articles.
1. [1]Allstadt, S.D., Rodriguez, C.O., Jr., Boostrom, B., Rebhun, R.B.Skorupski, K.A.(2015): Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. J Vet Intern Med. 29: 261-267.
2. [2]Arnold, E.J., Childress, M.O., Fourez, L.M., Tan, K.M., Stewart, J.C., Bonney, P.L.Knapp, D.W. (2011): Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 25: 1385-1390.
3. [3]Azémar, M.D., Comperat, E., Richard, F., Cussenot, O., Rouprêt, M. (2011): Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 29: 130-136.
4. [4]Bradbury, M.L., Mullin, C.M., Gillian, S.D., Weisse, C., Bergman, P.J., Morges, M.A., May, L.R., Vail, D.M., Clifford, C.A. (2021): Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy. Can Vet J. 62: 133-140.
5. [5]Bryan, J.N., Keeler, M.R., Henry, C.J., Bryan, M.E., Hahn, A.W., Caldwell, C.W. (2007): A population study of neutering status as a risk factor for canine prostate cancer. Prostate. 67: 1174-1181.